Evolent Health Inc (EVH) stock has gained 179.72% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives EVH stock a score of 65 out of a possible 100. That rank is influenced by a long-term technical score of 99. EVH's rank also includes a short-term technical score of 97. The fundamental score for EVH is 1. In addition to the average rating from Wall Street analysts, EVH stock has a mean target price of $25.83. This means analysts expect the stock to fall 19.97% over the next 12 months.
Is Evolent Health Inc (EVH) Stock Worth a Buy Thursday?
EVH has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on EVH!